Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader advised Mithril II LP on its successful effort, together with M28 Capital, Population Health Partners, Polaris Partners and Adimab LLC, to add three directors to the classified board of biopharmaceutical company Adagio Therapeutics, Inc. https://www.cadwalader.com/news/news-release/cadwalader-advises-mithril-on-adagio-proxy-contest-victory-